TMO vs ZBH
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | ZBH |
|---|---|---|
| Price | $675.00 | $91.04 |
| Market cap | $249.58B | $17.36B |
| P/E ratio | 36.4 | 22.1 |
| ROE | 13.51% | 6.41% |
| Profit margin | 15.04% | 9.48% |
| Revenue growth | 10.50% | 4.80% |
| Dividend yield | 0.28% | 1.05% |
| Beta | 0.85 | 0.47 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs ZBH in plain English
- TMO is the bigger company — about 14.4× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 22.1 vs 36.4).
- TMO earns a higher return on equity (14% vs 6%).
- TMO is growing revenue faster (10% vs 5%).
- ZBH has the higher dividend yield (1.05% vs 0.28%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.